.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer in 2014 for a whoppin...
.On the heels of a period 3 win that failed to make an impression on investors, Ironwood Pharmaceuti...
.Don't cease Monte Rosa Rehabs now. The Boston-based biotech is actually enjoying after authorizing ...
.Welcome to this week's Chutes & Ladders, our summary of notable leadership hirings, shootings an...
.Commemorating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer soun...
.AbbVie has gone back to the resource of its own antipsychotic giant Vraylar looking for an addition...
.GenSight Biologics is weeks off of lacking amount of money. Once more. The biotech only possesses s...
.Monopar Therapeutics is actually bouncing back a drug from the scrap heap of AstraZeneca's rare dis...
.With brand-new data out on Arcus Biosciences' experimental HIF-2a prevention, one team of professio...
.After creating a genetics therapy collaboration with Dyno Rehabs in 2020, Roche is back for additio...